BioLife Solutions (BLFS) Tops Q3 EPS by 4c, Beats on Revenue; Offers FY24 Revenue Guidance
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $26.04 +1.80%
EPS Growth %: +109.1%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: +109.1%
Financial Fact:
Total operating expenses: 2.35M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q3 EPS of ($0.04), $0.04 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $30.57 million versus the consensus estimate of $25.54 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $98-100 million, versus the consensus of $110.6 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Air France-KLM (AF:FP) (AFLYY) PT Raised to EUR13.50 at UBS
- Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
